Skip to main content

View full-text article in PMC

. 2015 Feb 24;10(2):e0117816. doi: 10.1371/journal.pone.0117816

Table 3. Findings of other studies investigating the association of CRC susceptibility SNPs with prognosis.

Study	Cohort size	Outcomes assessed	SNPs investigated
Study	Cohort size	Outcomes assessed	rs10318	rs10411210	rs10505477	rs10749971	rs10795668	rs10808555	rs10936599	rs11169552	rs11213809	rs11986063	rs12953717	rs1321311	rs13254738	rs1447295	rs16892766	rs16901979	rs1862748	rs1957636	rs355527	rs3802842	rs3824999	rs4444235	rs4464148	rs4779584	rs4813802	rs4925386	rs4939827	rs5934683	rs6687758	rs6691170	rs6983267	rs6983626	rs7013278	rs7014346	rs70195668	rs7136702	rs719725	rs7259371	rs7837328	rs961253	rs9929218
Abuli[17]	1,235	OS		x			+										x					x					x		x				x									x	+
Cicek[23]^γ	460	OS, DFS													x	x		x															x
Dai[18]^γ	285	OS, R	-	x	-	x	x	x			x	x	x				x		x		+	x		x	-				x				-	x		x				x	x	+	x
Garcia-Albeniz[24]^§	1,509	OS																											-
Hoskins[19]	583	OS	x		x		x															x			x	x			x				x		x	x			x
Passarelli[32]	727	CSS																							x				x
Phipps[20]^§	2,611	OS, CSS		x			x		x	x							x					x		x		x		x	-		x	x	x					x				x	x
Tenesa[21]	2,838	CSS		x			x										x					x		x		x			x				x									x	x
Xing[22]	380	OS, DFS					x						x									x				x			x								x

Key: + significantly increased survival,—significantly decreased survival, X no survival difference observed

OS—Overall survival, DFS—Disease free survival, CSS—cancer specific survival, R—recurrence

§—Based on overlapping cohort of patients

γ- Based on patients with stage II/III cancers.